MAP2K7 and cancer: Combining TNKS and RAS/MEK/ERK inhibition is therefore attractive strategies against colorectal cancer although induction of further feedback rescue mechanisms may require extensive combination of inhibitor treatments in order to fully eradicate the cancer [14].